News
Prolytic and Aeterna Zentaris – 20 years of improving human health together
For almost 20 years, Kymos’ German subsidiary Prolytic has accompanied Aeterna Zentaris in its development of pharmaceutical and diagnostic products. Katrin Dorfmeyer, Head of Chromatography, at Prolytic, and Dr. Michael Teifel, CSO at Aeterna (...) Read more
Quantifying Active Enzymes – A bioanalytical challenge
Lisa Hentschel, Master of Molecular Biosciences, started her career at Prolytic eight years ago as a technician in the ELISA team. Since 2017, she now leads the Biology Department and is a recognized expert (...) Read more
Nucleic Acids: From Biological Underdog to Biotech Top Dog
The bioanalysis of nucleic acids, especially in biological matrices, is one of the newest services offered by the Kymos Group and carried out at its German subsidiary Prolytic. Maria Fauth, Head of the Oligonucleotides (...) Read more
Kymos and ISGlobal join efforts to STOP parasitic diseases in Africa
“Kymos is a group with the highest ethical standards. This is not a PR statement but our day-to-day philosophy” Dr. Carles Celma, Scientific Director at Kymos stresses. “It was our pleasure to take an active (...) Read more
